Chiara Bellio, Ph.D., is currently the Associate Director and Precision Medicine Lead for Oncology at AstraZeneca, where they focus on delivering companion diagnostics and advancing oncology biomarker discovery. Previously, they served as a Senior Researcher at the Vall d´Hebron Institute of Oncology, leading projects on biomarkers related to drug-resistant cancer cells. Chiara's extensive research background includes a Ph.D. from Università degli Studi di Padova and postdoctoral positions at Harvard Medical School, where they investigated mechanisms of drug resistance in ovarian cancer. Their academic journey also features a Master's in Medical Biology and a foundational degree in Molecular Biology, both from Università degli Studi di Padova.
This person is not in the org chart
This person is not in any teams
This person is not in any offices